EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 191 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $280,000 | -62.7% | 6,700 | -58.4% | 0.00% | -100.0% |
| Q4 2020 | $750,000 | +13.1% | 16,100 | +16.6% | 0.00% | 0.0% |
| Q2 2020 | $663,000 | +5.1% | 13,813 | +0.7% | 0.00% | -50.0% |
| Q1 2020 | $631,000 | -61.3% | 13,713 | -49.4% | 0.00% | -50.0% |
| Q4 2019 | $1,630,000 | +434.4% | 27,127 | +573.1% | 0.00% | +300.0% |
| Q2 2018 | $305,000 | -30.7% | 4,030 | -51.7% | 0.00% | 0.0% |
| Q1 2018 | $440,000 | -95.3% | 8,348 | -95.3% | 0.00% | -95.7% |
| Q4 2017 | $9,412,000 | -26.9% | 176,186 | -18.4% | 0.02% | -32.4% |
| Q3 2017 | $12,882,000 | +4567.4% | 215,995 | +6071.3% | 0.03% | +3300.0% |
| Q2 2017 | $276,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |